Gabapentin Tablet
Product Images NDC 72888-131

Gabapentin, USP 600mg tablets manufactured by Rubicon Research Private Limited and distributed by Advagen Pharma Limited. These tablets are meant for oral consumption and should be stored at a temperature between 20°C to 25°C. The package insert contains the complete prescribing information. It is only to be dispensed with a pharmacist's prescription and preferably in a child-resistant container. Pharmacists should dispense an accompanying Medication Guide to each patient. For more information, visit the website www.advagenpharma.com/medguide.*

Gabapentin tablets are film-coated and contain 600mg of gabapentin, USP. They should be stored at a temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). The tablets should be kept in child-resistant containers and the accompanying medication guide should be provided to each patient. The tablets come in a container of 100 and are available only through prescription. For full prescribing information, refer to the package insert. The medication is distributed by Advagen Pharma Limited based in Plainsboro, NJ, USA.*

Gabapentin tablets USP 600 mg are prescription medicines that come in coated tablets. They are dispensed in a tight child-resistant container and must be kept in a temperature range of 20°C to 25°C (68°F to 77°F) with permissible excursions between 15°C and 30°C (59°F and 86°F). The corresponding medication guide must be given to each patient by the pharmacist. Keep this medicine out of the reach of children. For more information, refer to the package insert for the complete prescription information. The website to print medication guide is www.advagenpharma.com/medguide/gabapentintablets. The medicine is manufactured by Rubicon Research Private Limited, Ambernath, Dist. Thane, 421506 India and distributed by Advagen Pharma Limited, 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. Each bottle has 30 tablets, and the NDC code is 72888-131-30.*

Gabapentin is the active ingredient of each film-coated tablet which contains 600 mg of it. The package insert must be referred to for complete prescribing information. The tablets need to be kept at a temperature between 20°C to 25°C (68°F to 77°F), but short excursions between 15°C and 30°C (59°F and 86°F) are permitted, and should also be dispensed in a tight (USP), child-resistant container. Further, the medication guide should be printed and given to each patient. This drug is exclusively prescribed and should be kept out of reach from children. The batch is distributed by Advagen Pharma Limited, operating from Plainsboro Road Suite 605, Plainsboro, NJ, and is manufactured by Rubicon Research Private Limited Ambernath, Dist. Thane, 421506 India, as per Mfg Lic No. : KD-682.*

This is a description of Gabapentin Tablets, USP 800 mg which is enclosed in a film coat. The tablets can be stored at room temperature between 20°C and 25°C, with the exception of temperature excursions between 15°C and 30°C. The medication comes in a child-resistant container. Patients are advised to check the package insert for full prescribing information and to keep this and all drugs out of the reach of children. Pharmacists should distribute the medication guide to each patient. The medication is manufactured by Rubicon Research Private Limited, India, and distributed by Advagen Pharma Limited, USA.*

Gabapentin Tablets USP containing 800 mg of Gabapentin per coated tablet, with dosage and usage instructions available in the package insert. The tablets should preferably be stored at room temperature within 20°C to 25°C range and can be stored in the excursions of 15°C to 30°C range. They should be dispensed in a tightly closed (USP) and child-resistant package. Keep the medication out of the reach of children. Advagen Pharma Limited distributes these tablets, which have an NDC code of 72888-132-01, and are manufactured by Rubicon Research Private Limited in India. Pharmacists must provide a medication guide to each patient.*

Each film-coated tablet contains 800 mg of Gabapentin, USP. The dosage and usage instructions are mentioned in the package insert along with full prescribing information. The tablets should be stored at room temperature, and the containers should be tight and child-resistant. The medication guide can be printed from www.advagenpharma.com/medguide/gabapentintablets. This medication is prescribed only with the prescription of a qualified healthcare professional. The pharmacist must dispense the medication guide to each patient. The manufacturer of this medication is Rubicon Research Private Limited Ambernath, Dist. Thane, 421506 India.*

Each film-coated tablet contains 800 mg of Gabapentin. It is distributed by Advagen Pharma Limited and should be stored at room temperature. The dosage and usage instructions must be read before use. The medication guide should be given to each patient along with the tablets. The drug should be kept out of the reach of children and must be dispensed in a tightly closed child-resistant container. Manufacturing license number is KD-682. For more details, visit the website www.advagenpharma.com/medguide/gabapentintablets.*

This is a graph showing the mean pain score over a 12-week period, divided into a 4-week dose titration period and a 4-week fixed dose period. The experiment compares the pain score of a placebo group and a group taking Gabapentin at a dosage of 3600 mg/day. The x-axis shows the weeks, while the y-axis shows the mean pain score.*

This appears to be a chart showing the Week Dose Titratio n Period and 4-Week Fixed Dose Period for a drug study involving a placebo and different doses of Gabapentin. It also includes the mean pain score over several weeks.*

This is a figure showing the proportion of responders in controlled PHN (Postherpetic neuralgia) studies. The graph illustrates the percentage of patients with a 50% reduction in pain score at the end of the study. The figure shows the results of two studies where patients received different doses of medication. "PBO" represents the placebo group, and "GBP" refers to the medication dosage. There are no available details about the medication or the study's publisher.*